Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy
about
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironmentHematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironmentExploring the tumor microenvironment with nanoparticlesCancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platformα2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.Theranostic Probes for Targeting Tumor Microenvironment: An Overview.Interstitial fluid flow in cancer: implications for disease progression and treatment.Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniquesFibroblast heterogeneity in the cancer wound.Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer.WNT16B from ovarian fibroblasts induces differentiation of regulatory T cells through β-catenin signal in dendritic cellsClinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality.Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis.Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblastsA fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs.The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.[Tumor Associated Fibroblasts Promote PD-L1 Expression in Lung Cancer Cells].Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in miceTargeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.Computational selection of antibody-drug conjugate targets for breast cancer.A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma.Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal culturesAnti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapyTranscriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.Carcinoma-associated fibroblasts are a promising therapeutic target.Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumorsQuantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Molecular imaging with engineered physiology.Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.
P2860
Q26853374-BA15089E-AC74-4663-909E-95D1207FA728Q28080529-824FE911-3F5F-4FEA-9EE4-47827BB761B4Q28082374-26BD13FA-0422-44F7-94ED-A805F16CCA7FQ28545862-17AAA7A9-EE0E-49E7-B219-D6FA5B724E64Q30248728-39BA8E57-4F63-4C85-9656-42E253A0770DQ30354655-99115CA7-E382-4ECB-BC59-E02D4749561BQ30411142-6C801A86-3B5E-4761-BF2A-226B1F1B9DC4Q33833031-9061CE04-0C31-4263-A990-75E2749BAAF2Q33964324-FB5A04A5-B30E-4194-8FD3-6BDA0EB1A286Q34037014-DE832DDE-82B5-441E-A8AB-88857368EDE5Q34072554-270B5B88-063B-4E56-A3D6-8BBE99762857Q34115941-547F29EC-C192-42F2-9F81-D5ECE516EC98Q34308855-9C1CDF18-6810-4C7B-A379-026BBDC202B8Q34473048-9FF7ECDF-475A-4C4C-A317-59545DDBC77FQ35040181-9D01B340-69F1-4856-AAEC-CC63E997EBFEQ35088390-829C0A01-0597-4DA7-AAF8-FCF5B4292BBFQ35182174-1EB293E6-1761-4A8C-9E57-9B4F36A0DF02Q35195876-9DF7A641-B87C-4A07-A1BC-8BCFEE2ED8E0Q35666119-C2071512-54AE-4429-A7C2-862DDFC02257Q36099453-8AD29A66-CB3D-45D4-BD98-A355632358F9Q36253134-495EBDDE-A584-41BA-9E8C-33476C1E075FQ36356011-C0CC8D66-B22E-4652-A471-1BE4B556ECAFQ36378059-F0835C5B-8E96-42D4-AEED-32012E9C9AC9Q36406528-84679854-ED90-46C9-A7B7-BB527F63FE70Q36433471-DAD5B5B9-7EF1-4CA7-A6A7-9E6FC18EFC5FQ36470281-EF309B84-4DC5-444A-8475-9D8E641D675EQ36486772-998EC76B-B48F-4F61-B0EA-0D224D3945BAQ36771856-AFE1CD84-8C81-4937-9DED-78C6FEEE9394Q36777149-1804FC21-54DC-4B8C-A965-B817A33ECB16Q36867662-65EC2AC3-7460-487C-B37F-67DBA056B18AQ36998991-D4789D31-EB3D-43A1-9000-C2838136EFDEQ37046579-863F8AE1-A2E0-4139-8731-BDF9B36876B6Q37061749-296F4CBC-7A71-4B04-BCC4-D778373DFA7DQ37113270-E1117195-D7C6-48C9-8E20-E8BD0F005954Q37147318-D2EB4D15-8160-41F1-B8B9-BB70735FB27BQ37268993-4D9A2174-A017-4683-A1FC-8D06EBACE121Q37410661-4ED2BE59-E3A8-4493-BB91-9AA10E42E113Q37486959-E210E014-94A3-441C-BFA4-F9D9AF95C4CBQ37488703-D718C5FA-7732-4EE3-B905-28146B8D6F66Q37709413-2F905DB9-1BDD-4FA4-B9D3-81F33BAE8517
P2860
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@ast
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@en
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@nl
type
label
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@ast
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@en
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@nl
prefLabel
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@ast
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@en
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@nl
P2093
P2860
P3181
P1476
Rationale behind targeting fib ...... ovel chemotherapeutic strategy
@en
P2093
J. T. Isaacs
S. R. Denmeade
W. N. Brennen
P2860
P304
P3181
P356
10.1158/1535-7163.MCT-11-0340
P407
P577
2012-02-01T00:00:00Z